Return to homepagePandemic Pact

A phase I study on the pharmacokinetics of anti-SARS-CoV2 virus neutralizing antibodies in middle aged and elderly volunteers. Towards evidence-based dosing of convalescent plasma for COVID-19

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 1.04301E+13

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2021

  • Known Financial Commitments (USD)

    $155,050

  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)

  • Principal Investigator

    Dr PhD. BJA Rijnders

  • Research Location

    Netherlands

  • Lead Research Institution

    Erasmus MC

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Phase 1 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase I

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)Older adults (65 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract